Literature DB >> 30605536

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

Freddy Caldera1, Mary S Hayney2, Raymond K Cross3.   

Abstract

Entities:  

Keywords:  herpes zoster; inflammatory bowel disease; infliximab; number needed to harm; tofacitinib; vedolizumab

Mesh：

Substances：

Year:  2019        PMID： 30605536     DOI： 10.1093/ibd/izy387

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  4 in total

1.  Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.

Authors:  Sheena Crosby; Michael J Schuh; Freddy Caldera; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-01

Review 2.  Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease.

Authors:  Britta Siegmund
Journal:  J Crohns Colitis       Date:  2020-08-01       Impact factor: 9.071

Review 3.  Health Maintenance for Adult Patients with Inflammatory Bowel Disease.

Authors:  Jana G Hashash; Michael F Picco; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2021-11-22

Review 4.  Vaccination strategies for Korean patients with inflammatory bowel disease.

Authors:  Yoo Jin Lee; Eun Soo Kim
Journal:  Korean J Intern Med       Date:  2022-08-08       Impact factor: 3.165
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.